Schedule 13D ownership disclosure

DelMar Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 247078108

Event date: 2017-06-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001640334-17-001210
Form type
SC 13D
Filer
TuHURA Biosciences, Inc./NV
CIK
CIK 1498382
Filed
Jun 12, 2017
Reporting period
Jun 12, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub